ssalz’s Activity

Mon May 4

NL

Boards Post

ssalz posted to the ISIS Pharmaceuticals board. 9:34 AM

More news

CARLSBAD, Calif., May 4, 2015 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) has entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of thrombosis. Under the [more]

Fri May 1

NL

Boards Post

ssalz posted to the ISIS Pharmaceuticals board. 12:21 PM

New milestone payment

The Wall Street Journal news department was not involved in the creation of this content.
PRESS RELEASE
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen
April 30, 2015 4:36 p.m. ET
CARLSBAD, Calif., April 30, 2015 [more]

Mon Apr 13

NL

Boards Post

ssalz posted to the Alnylam Pharmaceuticals board. 9:19 AM

A Primer on RNA interference from RGLS

About microRNAs

The discovery of microRNAs in humans during the last decade is one of the most exciting scientific breakthroughs in recent history. microRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not [more]

NL

Boards Post

ssalz posted to the Regulus Therapeutics, Inc. board. 9:18 AM

A primer of RNA interference

About microRNAs

The discovery of microRNAs in humans during the last decade is one of the most exciting scientific breakthroughs in recent history. microRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not [more]

Fri Apr 10

NL

Boards Post

ssalz posted to the Regulus Therapeutics, Inc. board. 8:49 AM

WSJ article includes RGLS

Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, recently announced that the European Commission has granted orphan medicinal product designation [more]

Wed Apr 8

NL

Boards Post

ssalz posted to the Regulus Therapeutics, Inc. board. 8:33 AM

Another positive

LA JOLLA, Calif., April 7, 2015 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), [more]

Mon Mar 23

NL

Boards Post

ssalz replied to the ISIS Pharmaceuticals board. 9:00 PM

Re: Another promising event

Hopefully, both as an investor and a physician Dr. Steve

Fri Mar 6

NL

Boards Post

ssalz replied to the Berkshire Hathaway board. 9:41 PM

Re: BRK basis question

Thanks, Dr. Steve

NL

Boards Post

ssalz posted to the Berkshire Hathaway board. 7:49 PM

BRK basis question

1 b share say around 2001 worth 1800 per share. How to translate that into todays shares for a basis for selling. I forgot how many times the stock split.

Thanks, Dr. Steve

Tue Mar 3

NL

Boards Post

ssalz replied to the ISIS Pharmaceuticals board. 9:17 AM

Re: GSK MILESTONE

PS won't somebody come to the RGLS board. It is lonely there. I am the creator and only poster on the board for 1 whole year. Dr. Steve

NL

Boards Post

ssalz replied to the ISIS Pharmaceuticals board. 9:16 AM

Re: GSK MILESTONE

I think that it is "all about the science". If it holds up this will be a "rocket shoot" if it doesn't we chalk it up to experience and don't invest in early science. I think from everything I have read that the science will [more]

Sat Feb 28

NL

Boards Post

ssalz posted to the Berkshire Hathaway board. 8:00 PM

BRK price

How can I find the price of BRK stock in January 2002.

thx. Dr. Steve

Fri Feb 27

NL

Boards Post

ssalz posted to the ISIS Pharmaceuticals board. 9:59 AM

Year end wrap up pretty good

"2014 was another year of significant achievements for Isis with successes in every aspect of our business. We continued to advance our large pipeline of first-in-class or best-in-class drugs, including initiating Phase 3 programs for [more]

Wed Feb 25

NL

Boards Post

ssalz posted to the ISIS Pharmaceuticals board. 8:56 AM

Beat "on"

The science continues good.

/www.wsj.com/articles/PR-CO-20150224-912737?tesla=y&tesla...

Fri Feb 20

NL

Boards Post

ssalz replied to the Berkshire Hathaway board. 11:16 AM

Re: Basis question

Thanks, Dr. Steve

NL

Boards Post

ssalz posted to the Berkshire Hathaway board. 10:39 AM

Basis question

I bought BRK stock in 1999-2001 at prices of about $2K per share. What is the basis now that the stock has been split a few times and how do you calculate it. I can't remember how many splits etc.

Thanks, Dr. Steve

Tue Feb 10

NL

Boards Post

ssalz posted to the Alnylam Pharmaceuticals board. 8:34 AM

The first bump in the road

RGLS is closely related to ALNY and ISIS. They use the same technology.And also some of the same people.


Regulus RGLS, -7.24% shares dropped 10% to $15.15, as it appeared its drug, now designated as RG-101, will have to be accompanied [more]

NL

Boards Post

ssalz posted to the Regulus Therapeutics, Inc. board. 8:32 AM

The first bump in the road

Regulus RGLS, -7.24% shares dropped 10% to $15.15, as it appeared its drug, now designated as RG-101, will have to be accompanied by other treatments in many patients in order to cure Hepatitis C.

The company said RG-101 appeared to wipe out [more]

Thu Feb 5

NL

Boards Post

ssalz replied to the ISIS Pharmaceuticals board. 8:38 AM

Re: ISIS recent drop

There are those that don't know and those that don't know that they don't know. The story of ISIS; RGLS: and ALNY is right now all about the science. That is all that we can surmise at this time. As long as the science looks good, the stock [more]

NL

Boards Post

ssalz posted to the ISIS Pharmaceuticals board. 8:33 AM

The beat continues

PRESS RELEASE
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancing New Drug Into Development to Treat a Neurodegenerative Disease
Feb. 5, 2015 7:06 a.m. ET
--Fourth Drug to Enter Development Under Broad [more]

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75192
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 0
Best Pick ( 0)
Worst Pick ( 0)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to ssalz’s CAPS page

Boards Stats & Trivia

Big red star, 1000 posts Old School Fool
Board Posts 1024
Recs Received 2263
People who have rec'd these posts 584
Recs to Posts Ratio (last 30 days) N/A
Threads Started 346
Threads Started Percentage 33.79 %
Most Frequent Board Berkshire Hathaway
Very First Post Re: Amgen valuation (6/8/1999)
Percentage of Posts Rec'd 52.15 %
Show ssalz’s 10 Latest Posts